Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tolerance and Acceptance of a High Protein Nutrition Shake in Individuals Treated With the GLP-1 Receptor Agonist Semaglutide: a Single Arm, Open Label Study

NCT07096739 is registered in ClinicalTrials.gov with Kate Farms Inc as lead sponsor.

NCT NCT07096739
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07096739 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tolerance and Acceptance of a High Protein Nutrition Shake in Individuals Treated With the GLP-1 Receptor Agonist Semaglutide: a Single Arm, Open Label Study
Lead sponsor
Kate Farms Inc
Phase
Not applicable
Overall status
Completed
Start date
August 1, 2025
Completion date
September 19, 2025
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glp-1 concentration